Market reports & researches
LOG IN | Services | Contact | Custom Research



Main Healthcare, Pharmaceuticals & Biotechnology Healthcare and drugs
Publications

(Currently 512486 Items)


Partners


HEALTHCARE AND DRUGS / Total: 18950
PREVIOUS | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | NEXT
Title Date Price
This report analyzes the worldwide markets for Pipettes and Pipetters both Thousand & Million Units and . Thousands of US$. The specific product segments analyzed are Electronic Pipettors, Mechanical Pipettors,... Aug, 2006 €2 611
Ranking of major clinical laboratories by sales/profit valueStrategic analysis on the top laboratories: Recent sales achievements, major target fields of clinical trial, etc.Contract research: Sales ranking... Mar, 1999 €872
This “Sector Snapshot” is designed to provide a high-level overview of a particular market sector, including key players, sales data and emerging trends. This sector snapshot covers the independent... Oct, 2006 €374
The purpose of this analysis is to describe the specific market segments of the over-the-counter (OTC) diagnostic products and home healthcare markets. It examines the diagnostic measurement devices and... Sep, 2006 €2 541
To deflect the cost of chronic care, the scope of healthcare has broadened to embrace prevention. Using a variety of tools and methodologies, more healthcare organizations are striving to pinpoint that... Oct, 2006 €122
1. Overviews of point-of-care testing market2. Major players strategy: market analysis and study on noteworthy companies3. Individual company profile of researched companies4. Overseas (the US) market... Apr, 2003 €872
This report is the result of extensive, in-depth research, analysis and interviews with key executives and scientists from a wide range of companies and universities currently involved in research and... Jan, 2001 €10 000
This Frost & Sullivan research service entitled Latin American Rapid Tests Market for Infectious Diseases provides an overview on the Latin American region in terms of its stage of development in this... Jun, 2006 €2 242
The last decade witnessed tremendous growth in the HIV diagnostics and management markets. Relentless efforts by activists, healthcare workers and scientists have brought HIV disease management to the... Mar, 2000 €2 951
Limited Awareness of Sexually Transmitted Diseases Stunts the Growth of a Dynamic MarketThe asymptomatic nature of many sexually transmitted diseases (STDs) retards growth of the infectious disease diagnostic... May, 2003 €2 951
Developing Countries Emerging as Key Markets for Diabetes Monitoring Devices The demand for glucose self-monitoring devices has seen tremendous growth in recent years. Developing countries are rapidly... Apr, 2004 €3 699
Autoimmune Testing Market Becomes the New Source of Growth for In Vitro Diagnostics Companies Due to stagnating revenue growth and reimbursement pressures, in vitro diagnostics (IVD) companies are looking... Nov, 2004 €3 699
Emerging Technologies and Expanded Applications of Existing Products Will Drive Market GrowthThe use of molecular-based diagnostic solutions is expanding to other diseases. For example, the viral load... Jun, 2003 €2 951
This Frost & Sullivan research service, entitled U.S. Blood Pressure Monitoring Equipment Market, provides market revenue forecasts, drivers and restraints, and challenges and strategic recommendations.... Mar, 2006 €4 483
Increased understanding of the genetic basis of diseases has led to a considerable growth in the market for genetic testing. Traditionally, clinical diagnostics have been product-driven, but companies... Jun, 2000 €2 204
This report analyzes the key markets in the clinical laboratory analytical instrument industry, including the markets for clinical chemistry, immunoassay, integrated system, hematology, and coagulation... Jun, 1999 €2 578
Smaller Reagent Manufacturers Find New Solutions to Match Larger Manufacturers’ Advantage of Holding Reagent Rental Contracts Clinical laboratories enthusiasm for solutions that can help reduce huge... Feb, 2004 €2 951
The subject of this report is the management of diabetes in the United States. More specifically, however, the subject has been approached primarily through in-depth interviews with clinical and academic... Jan, 2001 €10 000
Superior Technology and Significant Clinical Benefits Drive PET-CT Adoption There has been a move away from stand-alone positron emission tomography (PET) imaging to PET-computed tomography (CT) as the... Dec, 2004 €2 951
Competitive pressures in the world X-ray and comuted tomography (CT) markets have never been greater. This Frost & Sullivan reports strategic focus on technology and product trends, international drivers... Jan, 1999 €2 951


PREVIOUS | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | NEXT
RSS